RBC Raises Price Target on Veeva Systems to $365 From $325
RBC Capital Markets increased its price target for Veeva Systems to $365 from $325 while maintaining an Outperform rating.
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
RBC Capital Markets increased its price target for Veeva Systems to $365 from $325 while maintaining an Outperform rating.
Needham analyst maintained a Buy rating on Veeva Systems and increased the price target from $310 to $360.
Filed: 2026-11-06 AccNo: 0001393052-26-000039 Size: 298 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Veeva Systems was honored with the 'Overall BioTech Solution of the Year' award for its 'Veeva Basics' offering by the BioTech Breakthrough Awards program.
Veeva Systems announced that pharmaceutical company UCB has committed to adopting Vault CRM, the company's agentic engagement platform for the life sciences industry.
Tom Schwenger, who served as President and Chief Customer Officer at Veeva Systems, has left the company to lead Omnicom Health's marketing business.